Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule
Journal Article
·
· Federal Register (Washington, D.C.)
OSTI ID:20939524
The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8 percent coal tar solution and 1.5 percent menthol in a shampoo drug product to control dandruff. FDA did not receive any comments or data in response to its previously proposed rule to include this combination. This final rule is part of FDA's ongoing review of OTC drug products.
- OSTI ID:
- 20939524
- Journal Information:
- Federal Register (Washington, D.C.), Journal Name: Federal Register (Washington, D.C.) Journal Issue: 72 Vol. 6; ISSN FEREAC; ISSN 0097-6326
- Country of Publication:
- United States
- Language:
- English
Similar Records
Topical tar: Back to the future
Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study
Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar
Journal Article
·
Sat Aug 15 00:00:00 EDT 2009
· Journal of the American Academy of Dermatology
·
OSTI ID:21222437
Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study
Journal Article
·
Sat Aug 01 00:00:00 EDT 1981
· Arch. Dermatol.; (United States)
·
OSTI ID:5455086
Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar
Journal Article
·
Wed Jun 01 00:00:00 EDT 1983
· J. Am. Acad. Dermatol.; (United States)
·
OSTI ID:6748535